Success Metrics

Clinical Success Rate
76.9%

Based on 10 completed trials

Completion Rate
77%(10/13)
Active Trials
1(7%)
Results Posted
60%(6 trials)
Terminated
3(21%)

Phase Distribution

Ph phase_1
3
21%
Ph phase_2
1
7%
Ph phase_3
4
29%
Ph not_applicable
1
7%

Phase Distribution

3

Early Stage

1

Mid Stage

4

Late Stage

Phase Distribution9 total trials
Phase 1Safety & dosage
3(33.3%)
Phase 2Efficacy & side effects
1(11.1%)
Phase 3Large-scale testing
4(44.4%)
N/ANon-phased studies
1(11.1%)

Highest Phase Reached

Phase 3

Trial Status & Enrollment

Completion Rate

76.9%

10 of 13 finished

Non-Completion Rate

23.1%

3 ended early

Currently Active

1

trials recruiting

Total Trials

14

all time

Status Distribution
Active(1)
Completed(10)
Terminated(3)

Detailed Status

Completed10
Terminated3
Recruiting1

Development Timeline

Analytics

Development Status

Total Trials
14
Active
1
Success Rate
76.9%
Most Advanced
Phase 3

Trials by Phase

Phase 13 (33.3%)
Phase 21 (11.1%)
Phase 34 (44.4%)
N/A1 (11.1%)

Trials by Status

terminated321%
completed1071%
recruiting17%

Recent Activity

1 active trials
Showing 5 of 14
terminatedphase_1

An Exploratory Study to Investigate the Effect of FE 999302 When Given Together With Follitropin Delta at Different Time Intervals During Controlled Ovarian Stimulation.

NCT06511791
terminatedphase_1

An Exploratory Study to Investigate the Effect of FE 999302 When Given Together With Follitropin Delta During Controlled Ovarian Stimulation

NCT06466486
completed

Retrospective Study of High Dose Follitropin Delta in a Mixed Protocol With Human Chorionic Gonadotropin

NCT05873725
recruiting

Real-world Evidence on Follitropin Delta Individual Dosing

NCT05173597
completednot_applicable

Cumulative Pregnancy Rate With Lower and Higher Gonadotropin Dose During IVF Among Poor Responders

NCT05103228
View all 14 trials

Clinical Trials (14)

Showing 14 of 14 trials
NCT06511791Phase 1

An Exploratory Study to Investigate the Effect of FE 999302 When Given Together With Follitropin Delta at Different Time Intervals During Controlled Ovarian Stimulation.

Terminated
NCT06466486Phase 1

An Exploratory Study to Investigate the Effect of FE 999302 When Given Together With Follitropin Delta During Controlled Ovarian Stimulation

Terminated
NCT05873725

Retrospective Study of High Dose Follitropin Delta in a Mixed Protocol With Human Chorionic Gonadotropin

Completed
NCT05173597

Real-world Evidence on Follitropin Delta Individual Dosing

Recruiting
NCT05103228Not Applicable

Cumulative Pregnancy Rate With Lower and Higher Gonadotropin Dose During IVF Among Poor Responders

Completed
NCT03738618Phase 3

Recombinant FSH Investigation in the Treatment of Infertility With Assisted Reproductive Technology (ART) (RITA-2)

Completed
NCT03740737Phase 3

Recombinant FSH Investigation in the Treatment of Infertility With Assisted Reproductive Technology (ART) (RITA-1)

Completed
NCT03697031

Impact of Blastocyst Morphological Development and Blastocoele Re-expansion on Pregnancy Outcome After Using REKOVELLE®

Terminated
NCT03296527Phase 3

Efficacy and Safety of FE 999049 in Controlled Ovarian Stimulation in Pan-Asian Women

Completed
NCT03228680Phase 3

Efficacy and Safety of FE 999049 in Controlled Ovarian Stimulation in Japanese Women

Completed
NCT04150861Phase 1

Rekovelle PK Trial in Chinese Women

Completed
NCT03393780

Study to Assess the Patterns of Use of REKOVELLE® in Naïve Women Undergoing In Vitro Fertilisation or Intracytoplasmic Sperm Injection Procedures

Completed
NCT03830723Phase 2

Personalized Insemination Treatment Study

Completed
NCT04503707

Study to Assess the Design of Use of REKOVELLE® in Women Undergoing In Vitro Fertilisation or Intracytoplasmic Sperm Injection Procedures in Routine Clinical Practice

Completed

All 14 trials loaded

Drug Details

Intervention Type
DRUG
Total Trials
14